XML 108 R97.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity - Schedule of Share-based Compensation, Stock Options, Activity (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 27, 2024
USD ($)
$ / shares
shares
Stockholders' Equity Note [Abstract]  
Options, Outstanding at December 29, 2023 | shares 2,630
Options, Granted, Shares | shares 640
Options, Exercised, Shares | shares (315)
Options, Forfeited or expired, Shares | shares (147)
Options, Outstanding at December 27, 2024 | shares 2,808
Options, Exercisable at December 27, 2024 | shares 1,826
Outstanding at December 29, 2023, Weighted-Average Grant-Date Fair Value | $ / shares $ 46.38
Weighted Average Exercise Price, Options, Granted | $ / shares 37.81
Weighted Average Exercise Price,Options, Exercised | $ / shares 23.52
Weighted Average Exercise Price, Options, Forfeited or Expired | $ / shares 70.43
Weighted Average Exercise Price, Options Outstanding at December 27, 2024 | $ / shares 45.72
Weighted Average Exercise Price, Options Exercisable at December 27, 2024 | $ / shares $ 47.03
Weighted Average Remaining Contractual Term, Options, Outstanding at December 27, 2024 6 years 7 months 2 days
Weighted Average Remaining Contractual Term, Options, Exercisable at December 27, 2024 5 years 4 months 17 days
Aggregate Intrinsic Value, Options, Outstanding at December 27, 2024 | $ $ 3,961
Aggregate Intrinsic Value, Options, Outstanding at December 27, 2024 | $ $ 3,961